Transaction in Own Shares • May 17, 2016
Transaction in Own Shares
Open in ViewerOpens in native device viewer
As of May 13, Novozymes has purchased an accumulated 2,330,606 shares with a transaction value of DKK 685.9 million under the stock buyback program Novozymes announced in Company announcement No. 2, 2016 and initiated February 1, 2016. Under the program, Novozymes will buy back B shares worth up to DKK 2 billion in total during 2016.
The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:
| Number of shares | Average purchase price | Transaction value, DKK | |
|---|---|---|---|
| Accumulated, last announcement | 2,169,606 | 635,113,102 | |
| 9 May 2016 | 40,000 | 315.93 | 12,637,319 |
| 10 May 2016 | 28,000 | 316.34 | 8,857,609 |
| 11 May 2016 | 30,000 | 315.68 | 9,470,274 |
| 12 May 2016 | 35,000 | 315.55 | 11,044,322 |
| 13 May 2016 | 28,000 | 314.96 | 8,818,889 |
| Accumulated under the program | 2,330,606 | 685,941,515 |
May 17, 2016 Company announcement No. 25
Contact information [email protected]
Martin Riise (DK) +45 3077 0738 [email protected]
Nicolai Agerskov Kobborg (DK) [email protected]
Klaus Sindahl (USA) +45 5363 0134 [email protected]
In addition, transactions necessitated by Novozymes' previously established incentive programs have resulted in a net sale by Novozymes of 17,290 B shares in the period from May 9 to May 13, 2016. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.
Following the transactions stated above, Novozymes owns a total of 8,523,248 treasury shares, corresponding to 2.7% of the stock capital. The total number of shares in the company is 310,000,000 including treasury shares.
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 Novozymes A/S CVR number: 10 00 71 27 Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.